ADC Therapeutics SA — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
3
3/A
4
424B3
424B4
424B5
424B7
6-K
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
FWP
POS AM
POS EX
PRE 14A
RW
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 424B3 | FORM 424B3 | 0000950103-26-003830 | Mar 16, 2026 | — |
| EFFECT | — | 9999999995-26-000834 | Mar 16, 2026 | — |
| ARS | ARS | 0001628280-26-016511 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-016238 | Mar 10, 2026 | — |
| S-3 | FORM S-3 | 0000950103-26-003549 | Mar 10, 2026 | — |
| 10-K | 10-K | 0001628280-26-016491 | Mar 10, 2026 | Dec 31, 2025 |
| 8-K | FORM 8-K | 0000950103-26-002466 | Feb 23, 2026 | Feb 18, 2026 |
| 4 | FORM 4 | 0001628280-26-009278 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001628280-26-009275 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001628280-26-009282 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001628280-26-009280 | Feb 18, 2026 | Feb 13, 2026 |
| 4 | FORM 4 | 0001628280-26-009283 | Feb 18, 2026 | Feb 13, 2026 |
| SCHEDULE 13G/A | — | 0000902664-26-001151 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000947871-26-000186 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001193125-26-054764 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-016431 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015265 | Feb 13, 2026 | — |
| 8-K | FORM 8-K | 0000950103-26-000349 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001628280-26-001386 | Jan 8, 2026 | — |
| 424B3 | FORM 424B3 | 0000950103-25-016077 | Dec 12, 2025 | — |
| EFFECT | — | 9999999995-25-003703 | Dec 12, 2025 | — |
| 4 | FORM 4 | 0001628280-25-056171 | Dec 9, 2025 | Dec 6, 2025 |
| S-3/A | FORM S-3/A | 0000950103-25-015918 | Dec 9, 2025 | — |
| 4 | FORM 4 | 0001628280-25-056168 | Dec 9, 2025 | Dec 6, 2025 |
| 4 | FORM 4 | 0001628280-25-056169 | Dec 9, 2025 | Dec 6, 2025 |
| 4 | FORM 4 | 0001628280-25-056170 | Dec 9, 2025 | Dec 6, 2025 |
| 4 | FORM 4 | 0001628280-25-056172 | Dec 9, 2025 | Dec 6, 2025 |
| 8-K | FORM 8-K | 0000950103-25-015818 | Dec 5, 2025 | Dec 3, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-111601 | Nov 13, 2025 | — |
| S-3 | FORM S-3 | 0000950103-25-014521 | Nov 10, 2025 | — |
| 8-K | 8-K | 0001628280-25-050796 | Nov 10, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-051095 | Nov 10, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0001140361-25-040534 | Nov 5, 2025 | — |
| 4 | OWNERSHIP DOCUMENT | 0001104659-25-103336 | Oct 28, 2025 | Oct 27, 2025 |
| 8-K | FORM 8-K | 0000950103-25-013103 | Oct 14, 2025 | Oct 12, 2025 |
| 8-K | FORM 8-K | 0000950103-25-012514 | Sep 30, 2025 | — |
| S-8 | FORM S-8 | 0000950103-25-012566 | Sep 30, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-078614 | Aug 14, 2025 | — |
| S-8 | FORM S-8 | 0000950103-25-010208 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001771910-25-000006 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0001771910-25-000008 | Aug 12, 2025 | Jun 30, 2025 |
| 424B3 | FORM 424B3 | 0000950103-25-008637 | Jul 10, 2025 | — |
| EFFECT | — | 9999999995-25-002209 | Jul 9, 2025 | — |
| UPLOAD | — | 0000000000-25-007098 | Jul 7, 2025 | — |
| CORRESP | — | 0000950103-25-008512 | Jul 7, 2025 | — |
| S-3 | FORM S-3 | 0000950103-25-008153 | Jun 30, 2025 | — |
| 4 | FORM 4 | 0001628280-25-031894 | Jun 17, 2025 | Jun 13, 2025 |
| 4 | FORM 4 | 0001628280-25-031895 | Jun 17, 2025 | Jun 13, 2025 |
| SCHEDULE 13G | — | 0000902664-25-002745 | Jun 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-031893 | Jun 17, 2025 | Jun 13, 2025 |